CANNAINVESTOR Magazine December / January 2016 | Page 12

12

Digipath’s cannabis testing business is operated through its wholly owned subsidiary, Digipath Labs, Inc., which performs all cannabis related testing using FDA-compliant, state-of-the-art laboratory equipment.

Digipath Labs seeks to be the nation’s premier full-service testing lab for cannabis and ancillary cannabis infused products, consistent with its belief that both medical and recreational cannabis adhere to the same standards as other food and drugs.

The Company runs both an analytical and a microbiological laboratory for cannabis to serve growers, producers, caregivers, and all end users of cannabis and botanical products with its own proprietary sets of procedures and standards to operate effectively and deliver high-quality accurate results.

Digipath Labs’ mission is to provide pharmaceutical-grade analysis and testing to the cannabis industry to ensure consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of its client’s products through research, development, and standardization.

Recognizing that the legal cannabis industry’s youthfulness has resulted in a lack of structure and oversight, Digipath, as an industry leader, developed its lab testing solutions and technology to create structure and process in an effort to ensure maximum cannabis safety through education, testing, and certification.

An independent cannabis testing laboratory and media firm.